ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:07 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 263
Drug details and screening numbers
Drug Name: FR-180204
Drug ID: 263
Synonyms:
Brand name:
Target: ERK
Number of cell lines screened: 922
Screening concentration range(s): 0.078125 to 20 uM
Statistically significant associations identified = 2
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a59 |
EWSR1-FLI1_mut |
263 |
1 |
1 |
FR-180204 |
ERK |
17 |
902 |
3 |
4.92 |
3.99 |
-0.925 |
1.1 * |
1.1 * |
1.9 * |
1.37e-06 |
5.39e-37 |
7.83e-01 |
0.38 |
a89 |
BRAF_mut |
263 |
1 |
1 |
FR-180204 |
ERK |
78 |
841 |
3 |
4.93 |
4.63 |
-0.302 |
0.34 |
0.35 |
0.33 |
7.29e-06 |
7.62e-37 |
7.83e-01 |
1.3 |
All-tests volcano plot